Angelman Syndrome Treatment Market Size, Opportunities, Trends, Factors, Revenue Analysis For 2022–2030
Angelman Syndrome (AS) is a rare neurodevelopmental disorder caused by a genetic abnormality affecting the maternal copy of the UBE3A gene on chromosome 15. It affects approximately 1 in 15,000 individuals worldwide. AS is characterized by developmental delays, intellectual disabilities, speech impairments, motor difficulties, and a unique behavioral profile, including a happy demeanor,...
0 Compartilhamentos
134 Visualizações